ComparativeIn VitroActivities of LFF571 against Clostridium difficile and 630 Other Intestinal Strains of Aerobic and Anaerobic Bacteria

Comparative Susceptibilities to Fidaxomicin (OPT-80) of Isolates Collected at Baseline, Recurrence, and Failure from Patients in Two Phase III Trials of Fidaxomicin against Clostridium difficile Infection

(2011) Ellie J. C. Goldstein et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients

(2010) Xing Wang Gao et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Biology of Clostridium difficile: Implications for Epidemiology and Diagnosis

(2010) Carroll Karen C. et al.   Annual Review of Microbiology

Management ofClostridium difficileInfection: Thinking Inside and Outside the Box

(2010) Dale N. Gerding et al.   CLINICAL INFECTIOUS DISEASES

Fidaxomicin (OPT-80) for the treatment ofClostridium difficileinfection

(2010) Mark Miller   EXPERT OPINION ON PHARMACOTHERAPY

Treatment of Refractory/Recurrent C. difficile-associated Disease by Donated Stool Transplanted Via Colonoscopy

(2010) Sonia S. Yoon et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

New trends in Clostridium difficile virulence and pathogenesis

(2009) C. Denève et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Comparative in vitro activity of REP3123 against Clostridium difficile and other anaerobic intestinal bacteria

(2009) D. M. Citron et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Clostridium difficile infection: new developments in epidemiology and pathogenesis

(2009) Maja Rupnik et al.   NATURE REVIEWS MICROBIOLOGY

Clostridium difficile–associated diarrhea: an emerging threat to pregnant women

(2008) Nadine G. Rouphael et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

OPT-80 Eliminates Clostridium difficile and Is Sparing of Bacteroides Species during Treatment of C. difficile Infection

(2008) T. J. Louie et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Editorial Commentary:Decreased Effectiveness of Metronidazole for the Treatment ofClostridium difficileInfection?

(2008) Ed J. Kuijper et al.   CLINICAL INFECTIOUS DISEASES

Comparison of Clinical and Microbiological Response to Treatment ofClostridium difficile–Associated Disease with Metronidazole and Vancomycin

(2008) Wafa N. Al‐Nassir et al.   CLINICAL INFECTIOUS DISEASES

Emergence of reduced susceptibility to metronidazole in Clostridium difficile

(2008) S. D. Baines et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY